MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617004122 A) filed by Iksuda Therapeutics Limited, Newcastle Upon Tyne, U.K., on Jan. 15, for 'co-administration of antibody-drug conjugate.'
Inventor(s) include Lodge, Adam; Deckert, Jutta; Lutz, Robert; and Mysliwy, Justyna.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to antibody-drug conjugates (ADCs) that target the CanAg antigen and co-administration of the ADC with unconjugated antibody. In particular, the present invention relates to compositions (e.g. pharmaceutical compositions) comprising the ADCs and unconjugated antibody and methods of using the same, including for the treatment of cancer."
The patent application was internationally filed on Aug. 22, 2024, under International application No.PCT/GB2024/052205.
Disclaimer: Curated by HT Syndication.
